T1	Participants 117 123	adults
T2	Participants 946 1150	This 23-day, prospective, double-blind, randomized, parallel-group study was conducted at 3 Colombian centers: University Libre, Social Security Institute, and General Hospital of MedellÃ­n, Cali, Colombia
T3	Participants 1152 1438	Outpatients with cancer were eligible for the study if they were aged >-18 years and had chronic (duration, >/= 3 months) moderate to severe cancer-related pain (score on 10-cm visual analog scale [VAS], > 3 cm [moderate]; score on a 4-point verbal pain-intensity scale, > 1 [moderate])
T4	Participants 2301 2377	Of the total number of cases, 59% were aged 60 to 89 years, and 55% were men
